• BX Home
  • Business of Biotechnology: Blog [Page 13]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,248 news and 4,696 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Blogs

Recent blog posts on this topic.

Drug Patent Expirations for Mar 22 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Biotechs beat generics rivals in state biosimilars battlemore

Biotech industry honchos notched a first victory in their state-to-state campaign to raise the bar on use of...

Biogen Idec, Sanofi secure European nods for blockbuster MS hopefulsmore

Just days ahead of a big-time FDA decision on its oral multiple sclerosis pill, Biogen Idec grabbed the endorsement of...

UPDATED: Cerulean Pharma's lead nanodrug crashes in lung cancer studymore

Oliver Fetzer, CEO of Cerulean Pharma After raising more than $80 million in venture money, Cerulean Pharma failed its...

Which Drugs Have the Most Patents?more

Copyright © thinkBiotech This chart shows the pharmaceutical drugs with the most patents still in force.

Titan claims victory for anti-addiction drug after mixed FDA panel vot...more

Titan Pharmaceuticals ($TTNP) emerged victorious from an FDA advisory committee meeting where the majority of...

Amid more job cuts, AZ brings on GSK's Dunoyer as business chiefmore

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad)...

Drug Patent Expirations for Mar 2 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 5 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 11 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 12 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Bullish Acadia surges on PhIII data for Parkinson's drugmore

Shares of San Diego-based Acadia Pharmaceuticals ($ACAD) surged 28% this morning after the biotech spelled out some of...

See you in Pittsburgh in Early Aprilmore

Copyright © thinkBiotech I will be in Pittsburgh from April 4-5th to give  a talk at Carnegie Mellon’s business school,...

Teva touts fresh PhIII evidence of oral MS drug's potentialmore

Teva ($TEVA) and its multiple sclerosis partner Active Biotech rolled out some new top-line Phase III data on their...

Enanta prices IPO shares at low end of rangemore

Enanta Pharmaceuticals, which is partnered with AbbVie ($ABBV) on a hot new experimental therapy for hepatitis C, has...

UPDATED: Celgene makes big splash in gene therapy with two key cancer ...more

Celgene has made a move into the resurgent gene therapy field. With a focus on immunotherapies against cancer, Celgene...

UPDATED: AstraZeneca chops 2,300 more jobs, narrows R&D focus and ...more

AZ CEO Pascal Soriot AstraZeneca's new CEO Pascal Soriot has wrapped his review of the Big Pharma company ($AZN) and...

Drug Patent Expirations for Mar 2 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 5 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 11 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 12 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Access to Capital – The Answers are in the Crowd?more

Copyright © thinkBiotech This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a...

Biogen Idec advances blockbuster MS franchise on two key frontsmore

Biogen Idec has taken a couple of big steps forward in building up its blockbuster franchise for multiple sclerosis...

Aratana joins biotech IPO queue while Tetraphase takes a haircutmore

Aratana Therapeutics, which is developing 6 new treatments for cats and dogs, joined the biotech queue on Wall Street,...

Volatile BioLineRx shares decimated by PhII/III schizophrenia drug fai...more

Shares of Israel's BioLineRx ($BLRX) plunged 51% this morning when the biotech announced that it was shutting down a...

Top Sources: Business of Biotechnology

  • Biotech Blog
  • News
  • Health Beat
  • frontendofinnovation.blogspot.com
  • Nature Biotechnology
  • The Biotech Weblog
  • policyinnovations.org
  • Science Progress
  • LinkedIn Answers: Technology
  • World Pharma News / Published News

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: May 8
Research Associate - Biotechnology William Blair Company, L.L.C | New York, NY
Posted: Apr 19

Report comment contains invalid characters. ()
cancel
Search Cancel